Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The daily Top 10 COVID papers

  Breast Cancer

  Free Subscription


1 Am J Clin Pathol
1 Am J Pathol
1 Ann Surg
3 Ann Surg Oncol
1 Br J Cancer
1 Breast Cancer (Auckl)
2 Clin Breast Cancer
1 Eur J Cancer
2 Eur J Surg Oncol
1 PLoS One
1 Radiology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Clin Pathol

  1. VAN BOCKSTAL MR, Berliere M, Duhoux FP, Galant C, et al
    Interobserver Variability in Ductal Carcinoma In Situ of the Breast.
    Am J Clin Pathol. 2020;154:596-609.
    PubMed         Abstract available

    Am J Pathol

  2. HAN H, Yang C, Zhang Y, Han C, et al
    Vascular endothelial growth factor mediates the sprouted axonogenesis of breast cancer in rat.
    Am J Pathol. 2020 Dec 17. pii: S0002-9440(20)30561.
    PubMed         Abstract available

    Ann Surg

  3. GLEISNER AL, Moss A, Friedman C, Suresh K, et al
    De-Implementation of Axillary Dissection in Women with Breast Cancer is Largely Driven By Site-Level Contextual Effects.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed         Abstract available

    Ann Surg Oncol

  4. AGAFONOFF S, Kundu N, Schwarz G, Shah C, et al
    Immediate Implant Reconstruction in Patients Undergoing Radiation Therapy: Opportunities and Challenges.
    Ann Surg Oncol. 2020;27:963-965.

  5. CYR AE
    Underutilization of Enhanced Recovery After Surgery (ERAS) in Breast Surgery: An Opportunity to Reduce Opioid Usage.
    Ann Surg Oncol. 2020;27:966-968.

    Identifying Factors Predicting Long-Term Opioid Use After Mastectomy.
    Ann Surg Oncol. 2020;27:969-970.

    Br J Cancer

  7. TOSS MS, Abidi A, Lesche D, Joseph C, et al
    The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.
    Br J Cancer. 2020;122:1496-1506.
    PubMed         Abstract available

    Breast Cancer (Auckl)

  8. ALKUSHI A, Omair A, Arabi H, Masuadi E, et al
    Predictability of 21-Gene Recurrence Score Assay by Using Pathological and Immunohistochemical Parameters in Breast Cancer.
    Breast Cancer (Auckl). 2020;14:1178223420977848.
    PubMed         Abstract available

    Clin Breast Cancer

  9. KOPETTI C, Schaffer C, Zaman K, Liapi A, et al
    Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature Review.
    Clin Breast Cancer. 2020 Nov 10. pii: S1526-8209(20)30264.

  10. LA VERDE N, Collova E, Blasi L, Pinotti G, et al
    Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.
    Clin Breast Cancer. 2020 Nov 9. pii: S1526-8209(20)30272.
    PubMed         Abstract available

    Eur J Cancer

  11. BOERS J, Venema CM, de Vries EFJ, Hospers GAP, et al
    Serial [(18)F]-FDHT-PET to predict bicalutamide efficacy in patients with androgen receptor positive metastatic breast cancer.
    Eur J Cancer. 2020;144:151-161.
    PubMed         Abstract available

    Eur J Surg Oncol

  12. KOUWENBERG CAE, Mureau MAM, Kranenburg LW, Rakhorst H, et al
    Cost-utility analysis of four common surgical treatment pathways for breast cancer.
    Eur J Surg Oncol. 2020 Nov 28. pii: S0748-7983(20)31026.
    PubMed         Abstract available

  13. VANE MLG, Moossdorff M, van Maaren MC, van Kuijk SMJ, et al
    Conditional regional recurrence risk: The effect of event-free years in different subtypes of breast cancer.
    Eur J Surg Oncol. 2020 Nov 27. pii: S0748-7983(20)31018.
    PubMed         Abstract available

    PLoS One

  14. CIRIA-SUAREZ L, Jimenez-Fonseca P, Palacin-Lois M, Antonanzas-Basa M, et al
    Ascertaining breast cancer patient experiences through a journey map: A qualitative study protocol.
    PLoS One. 2020;15:e0244355.
    PubMed         Abstract available


  15. BAHL M, Mercaldo S, McCarthy AM, Lehman CD, et al
    Imaging Surveillance of Breast Cancer Survivors with Digital Mammography versus Digital Breast Tomosynthesis.
    Radiology. 2020 Dec 22:201854. doi: 10.1148/radiol.2020201854.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.